Selected Publication:
Taus, P; Petru, E; Gucer, F; Pickel, H; Lahousen, M.
Primary serous papillary carcinoma of the peritoneum: a report of 18 patients.
Eur J Gynaecol Oncol. 1997; 18(3):171-172
Web of Science
PubMed
Google Scholar
- Co-authors Med Uni Graz
-
Lahousen Manfred
-
Petru Edgar
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- Eighteen patients with primary papillary serous carcinoma of the peritoneum (PPSCP) were treated at the Department of Obstetrics and Gynecology of the University of Graz between 1980 and 1996. Primary tumours from other sites, particularly the pancreas and ovary, had been excluded. Because of extensive spread of the disease particularly in the upper abdomen, seven of the 18 patients (38%) underwent exploratory laparotomy only. Median overall survival time was 10 months (range 1-28+). This figure reflects the extent of spread of the disease at diagnosis on one hand, and that optimal cytoreductive surgery (residual disease < or = 2 cm) was possible only in six of the 18 patients (33%) on the other. The six patients with optimal cytoreduction had a better survival (range 4+ to 28+ months) than those who underwent less radical surgery. These data indicate, that, similar to primary ovarian cancer, the amount of residual disease may be an important prognostic factor in patients with PPSCP.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Aged -
-
Austria -
-
Chemotherapy, Adjuvant -
-
Combined Modality Therapy -
-
Cystadenocarcinoma, Papillary - diagnosis Cystadenocarcinoma, Papillary - mortality Cystadenocarcinoma, Papillary - therapy
-
Diagnosis, Differential -
-
Disease-Free Survival -
-
Female -
-
Humans -
-
Laparotomy -
-
Middle Aged -
-
Neoplasm Recurrence, Local -
-
Neoplasm Staging -
-
Peritoneal Neoplasms - diagnosis Peritoneal Neoplasms - mortality Peritoneal Neoplasms - therapy
-
Radiotherapy, Adjuvant -
-
Survival Rate -
-
Treatment Outcome -
- Find related publications in this database (Keywords)
-
primary serous papillary carcinoma of the peritoneum
-
residual disease
-
cytoreductive surgery
-
ovarian cancer